אנג'יימו
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
SUTIMLIMAB
Available from:
SANOFI ISRAEL LTD
ATC code:
L04AA55
Pharmaceutical form:
תמיסה לאינפוזיה
Composition:
SUTIMLIMAB 50 MG / 1 ML
Administration route:
תוך-ורידי
Prescription type:
מרשם נדרש
Manufactured by:
GENZYME EUROPE B.V., THE NETHERLANDS
Therapeutic area:
SUTIMLIMAB
Authorization date:
2023-10-25
